A5063171591- Gastrointestinal motility and disorders
- Advanced Chemical Sensor Technologies
- Gastroesophageal reflux and treatments
- Olfactory and Sensory Function Studies
- Gastrointestinal disorders and treatments
- Vascular anomalies and interventions
- Obesity, Physical Activity, Diet
- Child Nutrition and Feeding Issues
- Helicobacter pylori-related gastroenterology studies
- Intestinal Malrotation and Obstruction Disorders
- Tumors and Oncological Cases
- Diverticular Disease and Complications
- Infant Health and Development
- Gastrointestinal Tumor Research and Treatment
- Diabetes Treatment and Management
- Anorectal Disease Treatments and Outcomes
- Pharmacology and Obesity Treatment
- Peatlands and Wetlands Ecology
- COVID-19 Clinical Research Studies
- Respiratory Support and Mechanisms
- Pelvic floor disorders treatments
- Biliary and Gastrointestinal Fistulas
- Anesthesia and Pain Management
- Biochemical Analysis and Sensing Techniques
- Microscopic Colitis
University of Antwerp
2018-2023
Antwerp University Hospital
2022-2023
Universitair Ziekenhuis Brussel
2022
Mayo Clinic
2018
Mayo Clinic in Florida
2017-2018
Abstract Background Weight loss in response to the long‐acting GLP ‐1 receptor ( 1R) analog, liraglutide, is correlated with delay gastric‐emptying GE ). The aim of this pilot study was assess whether specific genetic variants 1R or TCF 7L2 are associated delayed and weight obese patients treated liraglutide short‐acting agonist, exenatide. Methods We evaluated individuals associations variations (rs6923761) (rs7903146) on T 1/2 from two trials that separately exenatide, 5 μg BID for 30...
Meckel's diverticulum is present in about 2% of the population. The literature reports 3.2% incidence tumors within diverticulum; are predominantly benign.The purpose this study was to evaluate malignant through systematic review and electronic medical records including pathology over 14 years at Mayo Clinic, Rochester, USA.A last 10 identified 37 citations with 402 patients (median age: 58 years; 68.9% males). predominant malignancy reported neuroendocrine tumor 84.6%, followed by...
Irritable bowel syndrome (IBS) is characterised by recurrent abdominal pain related to defaecation or associated with altered stool frequency consistency. Despite its prevalence, major uncertainties in the diagnostic and therapeutic management persist clinical practice.A Delphi consensus was conducted 20 experts from Belgium, consisted of literature review voting process on 78 statements. Grading recommendations, assessment, development evaluation criteria were applied evaluate quality...
Background Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder for which no diagnostic tools are currently available. Patients diagnosed using the Rome IV criteria and subtyped into diarrhea, constipation, or mixed phenotype based on their dominant stool pattern. A recent development in biomarker area analysis of volatile organic compounds (VOCs). The aim this study was to evaluate potential VOCs as phenotypic biomarkers IBS breath fecal samples. Materials methods Breath...
Irritable bowel syndrome (IBS) is a chronic disorder characterized by abdominal pain and an altered habit. The aim of this study was to evaluate the characteristics population visiting patient-centered informative website about IBS.Five digital surveys were used assess Rome IV criteria, red flag symptoms, healthcare use, psychological comorbidities, quality life, symptom severity, diet, physical activity. Patients divided into positive negative with being further subtyped based on dominant...